RARA and myeloid neoplasm: Additional mutations potentially cooperating with the translocation fusion product in leukemogenesis have been hitherto unreported in <i>ZBTB16-RARA</i> APL and were sought by application of a next-generation sequencing approach to detect those recurrently found in myeloid malignancies.